Glycation-lowering compounds inhibit ghrelin signaling to reduce food intake, lower insulin resistance, and extend lifespan

Lauren Wimer,Kiyomi R. Kaneshiro,Jessica Ramirez,Neelanjan Bose,Martin Valdearcos,Muniesh Muthaiyan Shanmugam,Dominique O. Farrera,Parminder Singh,Jennifer Beck,Durai Sellegounder,Lizbeth Enqriquez Najera,Simon Melov,Lisa Ellerby,Soo-Jin Cho,John C. Newman,Suneil Koliwad,James Galligan,Pankaj Kapahi

DOI: https://doi.org/10.1101/2022.08.10.503411

2024-05-02

Abstract:Non-enzymatic reactions in glycolysis lead to the accumulation of methylglyoxal (MGO), a reactive precursor to advanced glycation end-products (AGEs), which has been hypothesized to drive obesity, diabetes and aging-associated pathologies. A combination of nicotinamide, α-lipoic acid, thiamine, pyridoxamine, and piperine (Gly-Low) lowered deleterious effects of glycation by reducing MGO and MGO-derived AGE, MG-H1, in mice. Gly-Low supplementation in the diet reduced food consumption, decreased body weight, improved insulin sensitivity, and increased survival in leptin receptor-deficient ( ) and wild-type C57B6/J mice. Transcriptional, protein, and functional analyses demonstrated that Gly-Low inhibited appetite-stimulating ghrelin signaling and enhanced the appetite-satiating mTOR pathways within the hypothalamus. Consistent with these molecular findings, Gly-Low inhibited ghrelin-mediated hunger responses. When administered as a late-life intervention, Gly-Low slowed hypothalamic aging signatures, improved glucose homeostasis and motor coordination, and increased lifespan, suggesting its potential benefits in ameliorating age-associated decline.

Molecular Biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to improve obesity, diabetes and their related pathologies and prolong lifespan by reducing the glycosylation level. Specifically, the researchers developed a complex named Gly - Low, which is composed of alpha - lipoic acid, nicotinamide, piperine, pyridoxamine and thiamine, aiming to reduce the formation of methylglyoxal (MGO) and its derived advanced glycation end - products (AGEs). The paper explored the effects of Gly - Low in inhibiting ghrelin signal transduction, reducing food intake, decreasing insulin resistance and prolonging lifespan. The study used multiple models, including Leprdb mice (a diabetes model) and wild - type C57BL/6J mice, to verify the efficacy of Gly - Low and its mechanism of action. ### Main research questions: 1. **Reducing glycosylation level**: How to alleviate pathologies related to obesity and diabetes by reducing the levels of MGO and AGEs? 2. **Inhibiting ghrelin signal transduction**: Can Gly - Low reduce food intake by inhibiting ghrelin signal transduction? 3. **Improving metabolic health**: Can Gly - Low improve insulin sensitivity, reduce body weight and fat accumulation? 4. **Prolonging lifespan**: Can Gly - Low prolong lifespan through the above mechanisms? ### Research methods: - **Animal models**: Experiments were carried out using Leprdb mice and wild - type C57BL/6J mice. - **Molecular and functional analysis**: The effects of Gly - Low on the hypothalamus were studied through transcriptomics, proteomics and functional analysis. - **Detection of physiological indicators**: Physiological indicators such as food intake, body weight, blood glucose level, fat and lean mass were measured. - **Survival analysis**: The effect of Gly - Low on the lifespan of mice was evaluated. ### Research results: - **Reducing MGO and AGEs levels**: Gly - Low significantly reduced the levels of MGO and MG - H1 in the blood of Leprdb mice. - **Reducing food intake and body weight**: Gly - Low reduced the food intake of Leprdb mice and wild - type mice and led to a decrease in body weight. - **Improving insulin sensitivity**: Gly - Low improved insulin sensitivity and blood - glucose control. - **Prolonging lifespan**: Gly - Low significantly prolonged the lifespan of Leprdb mice. - **Inhibiting ghrelin signal transduction**: Gly - Low inhibited ghrelin signal transduction in the hypothalamus and enhanced the appetite - suppressing mTOR pathway. ### Conclusion: Gly - Low shows its potential in treating obesity and diabetes and their related pathologies by reducing the glycosylation level, inhibiting ghrelin signal transduction, improving metabolic health and prolonging lifespan. These findings provide new ideas for further developing treatment methods for these diseases.

Glycation-lowering compounds inhibit ghrelin signaling to reduce food intake, lower insulin resistance, and extend lifespan

PPARγ agonists delay age‐associated metabolic disease and extend longevity

GLP1 Receptor Agonists—Effects beyond Obesity and Diabetes

The Glyoxalase System in Age-Related Diseases: Nutritional Intervention as Anti-Ageing Strategy

Functional and multi-omic aging rejuvenation with GLP-1R agonism

Gluconeogenesis and PEPCK are critical components of healthy aging and dietary restriction life extension

Advanced glycation in D-galactose induced mouse aging model

SGLT2 Inhibitors as Calorie Restriction Mimetics: Insights on Longevity Pathways and Age-Related Diseases

SGLT inhibitors for improving Healthspan and lifespan

Preservation of blood glucose homeostasis in slow-senescing somatotrophism-deficient mice subjected to intermittent fasting begun at middle or old age

Inhibiting Receptor for Advanced Glycation End Product (age) and Oxidative Stress Involved in the Protective Effect Mediated by Glucagon-Like Peptide-1 Receptor on Age Induced Neuronal Apoptosis

daf-16/FOXO and glod-4/glyoxalase-1 are required for the life-prolonging effect of human insulin under high glucose conditions in Caenorhabditis elegans

Alpha-ketoglutarate, an endogenous metabolite, extends lifespan and compresses morbidity in aging mice

Pioglitazone Hydrochloride Extends the Lifespan of Caenorhabditis elegans by Activating DAF-16/FOXO- and SKN-1/NRF2-Related Signaling Pathways

Growth hormone receptor gene disruption in mature‐adult mice improves male insulin sensitivity and extends female lifespan

A Role for Advanced Glycation End Products in Molecular Ageing

Glycerol 3-phosphate phosphatase/PGPH-2 counters metabolic stress and promotes healthy aging via a glycogen sensing-AMPK-HLH-30-autophagy axis in C. elegans

Growth hormone‐releasing hormone deficiency confers extended lifespan and metabolic resilience during high‐fat feeding in mid and late life

Inhibition on α-Glucosidase Activity and Non-Enzymatic Glycation by an Anti-Oxidative Proteoglycan from Ganoderma lucidum

Sitagliptin Extends Lifespan of Caenorhabditis elegans by Inhibiting Insulin/Insulin-Like Signaling and Activating Dietary Restriction-Like Signaling Pathways

Diosgenin intervention: targeting lipophagy to counter high glucose diet-induced lipid accumulation and lifespan reduction